IndraLab
Statements
reach
"Our work provides a new perspective that OTUB2-IN-1, a small-molecule inhibitor that successfully targets OTUB2, may have clinical translational value for VC treatment.We further explored the mechanism by which OTUB2 promotes calcification by performing RNA-seq to identify changes in gene expression in response to OTUB2 overexpression."